There will be no more babies for April, the giraffe that enthralled viewers worldwide with two livestreamed pregnancies and births.
A U.S. judge in California on Sunday blocked Trump administration rules, which would allow more employers to opt out of providing women with no-cost birth control, from taking effect in 13 states and Washington, D.C.
The maker of a permanent contraceptive implant subject to thousands of injury reports and repeated safety restrictions by regulators said Friday that it will stop selling the device in the U.S., the only country where it remains available.
The maker of Taytulla birth-control treatment issued a nationwide recall in the United States on Tuesday over concerns that misplaced capsules in pill packs could cause unintended pregnancies.
A new study claims a birth control pill for men appears to be safe when used daily, but it’s not yet clear how well it works.
Strokes are the fifth-leading cause of death for adults in the United States.
An app designed to track fertility and prevent pregnancy in women 18 and older is the first to win US Food and Drug Administration approval to be marketed as a contraceptive, the agency announced Friday. The Natural Cycles app was approved as part of the agency’s new Digital Health Innovation Action Plan, designed to fast track approval for new low-to-moderate-risk devices.
Senator Richard Blumenthal joined Senator Chris Murphy and 33 others in Congress to introduce the “Protect Access to Birth Control Act.” The legislation would rescind the Trump Administration rule that allows companies to interfere with employees’ reproductive health decisions, and forces women to pay more for birth control.
Lupin Pharmaceuticals announced a nationwide recall of Mibelas 24 Fe, a chewable birth control tablet.
Washington state sued President Donald Trump on Monday over his decision to let more employers claiming religious or moral objections opt out of providing no-cost birth control to women.